Norton Rose Fulbright is recommended for its vast knowledge of competition issues within the life sciences sector, and personal data mandates concerning early access and clinical trials. Practice co-lead Marta Giner Asins is known for her expansive expertise in antitrust and competition issues within the life sciences and healthcare sector, while co-lead Karine Montagut specialises in M&A and investment issues. Christian Dargham is an expert in all matters concerning compliance, particularly investigations and compliance programmes, while Nadège Martin often assists with early access authorisations and licensing transactions.
Testimonials
Collated independently by Legal 500 research team.
‘Responsiveness, rigour and customer orientation characterise Karine Montagut and her team, who have strong expertise in M&A in the field of health and life sciences.’
‘Karine Montagut - beyond her expertise, her negotiation skills and her experience, Karine perfectly coordinates the various advisors involved in the files and positions herself as the client's preferred point of contact.’
‘Marie-Adélaïde de Fleurieu has strong M&A expertise, and is a very good negotiator, showing rigour and a sense of organisation.’
Key clients
- Pfizer
- Seqens
- Ramsay Générale de Santé
- Sanofi
- Abbott
- Medtronic
- SYNLAB
- Embecta
Work highlights
- Advising SEQENS on the acquisition, from Novartis, of the pharma site of CELLforCURE located in Les Ulis (Essonne department).
- Advising Medtronic’s Integrated Health Solutions division on the antitrust and contractual aspects of a new strategic partnership with La Poste’s Health and Autonomy division, relating to the creation of a multi-brand and multi-pathology digital platform aimed at improving patients’ medical care.
- Advising a leading French pharmaceutical laboratory on in-licensing transactions relating to e-health products/solutions in the heart failure, oncological and neurological fields.
Practice head
The lawyer(s) leading their teams.
Marta Giner Asins, Karine Montagut